Hydroxypyruvate has been shown to be an alternative substrate for lactate dehydrogenase. The clinical value of this "glycerate dehydrogenase' has been investigated on 60 patients admitted to the hospital with a provisional diagnosis of myocardial infarction. For comparison, lactate dehyd rogenase, a-hydroxybutyric dehyd rogenase, creatine kinase, aspartate transaminase, and alanine transaminase were also assayed at 37#{176}C. Normal ranges and methods of assay are given for each enzyme. Glycerate dehydrogenase has greater activity than any other enzyme and parallels lactate dehydrogenase and a-hydroxybutyric dehydrogenase in its time of peak activity and duration of increased activity. Clinical and biochemical evidence is provided to show that a-hydroxybutyric dehydrogenase is not specific for the cardiac isoenzymes. Of the enzymes studied, creatine kinase activity increases most quickly after myocardial infarction, and an exclusive role for its use in coronary care units is also suggested. 
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Additional Keyphrases
Catalysis of reduction of hydroxypyruvate by enzymes of human origin has recently been described (5, 6) . The evidence for the reversibility of the reaction has been presented (6) , and, by analogy with the enzyme involved in the reduction of pyruvate to (Boehringer Corp., London). All of these enzymes were assayed with a Model 8600 "Reaction Rate Analyzer" (LKB Instruments, Inc., Rockville, Md. 20852).
CK activity was measured by using an "activated" monotest kit (Boehringer Corp.,) with a Unicam SP 800 recording spectrophotometer, temperature control being provided by a Tecam water bath.
Normal Values
The normal ranges used in this study were all established at 37#{176}C on the same group of 280 apparently healthy volunteers who were not hospital patients.
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The distribution of each of these enzymes was lognormal and positively skewed, so the ranges given are the 98% confidence limits (8).
Results
Although
all the patients had the common presenting symptom of chest pain, sufficient to arouse the suspicion of myocardial infarction and to warrant hospital admission, they are divided into two groups. enzyme activities at some time that were above normal limits. Each time it was the CK that was supranormal.
Group
The first of these patients had a CK of 138 U/liter during the 24-48 h period. All the other enzyme assays done during this and the 0-12 and 48-72 h periods were consistently at the lower end of each normal range. This patient had electrocardiographic evidence of posterior myocardial ischemia.
The second patient had CK activities of 167 U/liter and 150 U/liter at the 24-48 and 48-72 h periods, respectively. All the other assays at these times together with the CK at the 0-12 h period remained well within normal limits. This patient had a myocardial infarction one month before his current admission.
The third patient had a CK of 300 U/liter at the 24-48 h period. All other assays at this and the 0-12 and 48-72 h periods were within normal limits. The electrocardiogram also suggested myocardial ischemia.
Discussion
Although the mean activities of the six enzymes assayed on sera from the patients in group 1 are shown in Figure 4 , this takes no account of the increase of activity of each enzyme relative to its normal range. In Figure 6 the upper limit of nor- mal for each enzyme is taken as unity and the mean increase of activity of each enzyme at each time interval is related to this upper limit.
The first important point that emerges from this study is the time of greatest elevation and the duration of elevation of each enzyme when measured at 37#{176}C. CK activity is greatest at 12-24 h and has virtually returned to normal by 73-96 h. This is similar to aspartate transaminase, although the graph ( Figure  6 ) suggests that this enzyme may reach its peak activity slightly later than does CK. The dehydrogenases parallel each other and reach their peak activities later than the other enzymes, at 25-48 h, and still show a mean activity at 73-96 h almost twice their upper limit of normal values.
There have been many other reports relating to the times of peak elevation of various enzymes (10-17, 19, 20) . optimal assay conditions at 37#{176}C. Our findings as to the timing of peak elevations under these conditions generally agree with the earlier reports. The activities with the substrates pyruvate, 2-oxobutyrate, and hydroxypyruvate so clearly parallel one another that this provides further supportive evidence that they are all substrates for the same enzyme, LDH. It has been suggested that 2-oxobutyrate provides a measure of the concentration of the fast-moving cardiac isoenzymes (18) , and that this leads to greater specificity as a test for myocardial infarction (19) . The LDH/a-HBD ratio has been found to be less than 1.23 in cases of myocardlial infarction and greater than 1.6 in cases of liver disease (19) . Again it has been argued that this shows that cr-HBD has greater specificity for the cardiac isoenzymes.
The evidence has previously been presented that this specificity is not inherent to the substrate 2-oxobutyrate but has been created by the use of suboptimal substrate concentrations at the nonphysiological temperature of 25#{176}C (5, 7). The original ratios do not hold under optimal concentrations at temperatures above 25#{176}C. In our normal ranges established at 37#{176}C the ratio of LDH/a-HBD is 1.15 to 3.19. In this series of patients with proven myocardial infarction, the ratio of LDH/a-HBD falls within this range and gives further proof that under optimal conditions at 37#{176}C ratios yield no useful information and that 2-oxobutyrate does not possess the specificity claimed for it.
One final point relating to a-HBD that emerges from this study is that LDH and a-HBD both reach peak activities of 3.3 times the upper limit of normal ( Figure  6 ), compared with the findings of Elliot and Wilkinson (20) of a mean peak activity for a-HBD of 4.5 times the upper limit of normal and for LDH of about 3 times the upper normal limit when suboptimal concentrations are used. The enzymes showing the greatest activity increase are CK, with a peak activity 6.1 times the upper limits of normal, and aspartate transaminase, 4.1 times. As expected, alanine transaminase activity shows no significant rise above its normal range.
The has too wide a range to be of value. Second, if optimal and the original concentrations are used for LDH and a-HBD (18, 19) , respectively, at 37#{176}C their ratios would be chemically doubtful but would also be difficult to keep sufficiently narrow to be of clinical use. We have shown in this paper that the usefulness of serum enzyme assays in the diagnosis of myocardial infarction is not diminished even when the artificial specificity of 2-oxobutyrate is not present. Glycerate dehydrogenase emerges as having a useful part to play in the diagnosis of myocardial infarction, as shown by the information it provides when measured with enzymes previously recognized as being of value in clinical diagnosis. It has the greatest activity of any of the enzymes and therefore lends itself to greater speed and accuracy in rate of reaction assays. It also adapts well to the increasing automation required in clinical chemistry.
By use of the LKB 8600 Reaction Rate Analyzer, more than 100 assays can be done per hour.
